Efficacy News and Research

RSS
Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Patient-derived circulating tumor cells could be used to identify drug targets for leptomeningeal disease

Patient-derived circulating tumor cells could be used to identify drug targets for leptomeningeal disease

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

Study evaluates heterologous vaccination scheme in children using two SARS-CoV-2 RBD protein vaccines

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies

Scientists predict structure of SARS-CoV-2 frameshifting pseudoknot

Scientists predict structure of SARS-CoV-2 frameshifting pseudoknot

Study shows anti-itch and pain relief potential of protein in tick saliva

Study shows anti-itch and pain relief potential of protein in tick saliva

SARS-CoV-2 variant identification by RT-qPCR assays targeting mutations

SARS-CoV-2 variant identification by RT-qPCR assays targeting mutations

French study shows COVID vaccine efficacy 94% against severe outcomes

French study shows COVID vaccine efficacy 94% against severe outcomes

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Clinical outcomes of regdanvimab usage in patients with mild to moderate COVID-19

Study offers new hope for patients coping with spinal cord injuries

Study offers new hope for patients coping with spinal cord injuries

Current progress in SARS-CoV-2 vaccine candidates

Current progress in SARS-CoV-2 vaccine candidates

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Patients divided over Alzheimer’s drug: Is it a ‘risk I’m willing to take’ or just a ‘magic pill’?

Patients divided over Alzheimer’s drug: Is it a ‘risk I’m willing to take’ or just a ‘magic pill’?

Binding efficacy of SARS-CoV-2 S1 specific salivary antibodies to the Omicron and Delta variants

Binding efficacy of SARS-CoV-2 S1 specific salivary antibodies to the Omicron and Delta variants

Combating COVID cytokine storm with targeted nucleic acid therapies

Combating COVID cytokine storm with targeted nucleic acid therapies

Microneedle treatments could significantly desensitize people with food allergies

Microneedle treatments could significantly desensitize people with food allergies

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.